Hematologist, Transplant Physician. | Opinions expressed are my own and not in any official or professional capacity. UPMC Hillman Cancer Center, Harrisburg
Harrisburg, PA
Joined September 2008
- Tweets558
- Following319
- Followers463
- Likes566
Pinned Tweet
Honored to speak at #ASH2025 in Orlando as part of the ASH Education Program. Great session on Rare B-Cell Malignancies in 2025
#Hematology #BCellMalignancies #Lymphoma #Leukemia #MedicalEducation #Oncology #ClinicalResearch
Salman Fazal M.D retweeted
New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification onlinelibrary.wiley.com/doi/… #mpnsm
Living with an MPN? Let's talk about symptoms. 🩸
Fatigue, itching, night sweats, an enlarged spleen, bone pain. For many people with polycythemia vera, essential thrombocythemia, or myelofibrosis, symptoms affect daily life as much as blood counts do.
On Monday, November 2 at 12:00 PM ET, I'll be joining HealthTree Foundation for a free online webinar: Understanding Your MPN Symptoms.
We'll leave plenty of time for live Q&A, so bring your questions. Can't make it live? Register anyway, and HealthTree will email you the recording.
Please share with anyone in your life affected by an MPN. 💙
#MPNsm #Myelofibrosissm #PolycythemiaVera #EssentialThrombocythemia
@BloodCancerUtd @MPN_RF @HealthTree @UPMCHillmanCC
👉 Register:
healthtree.org/events/nov26-…
Early in my career, I learned that not all heroes work in front of the patient.
Some work behind the scenes: on rounds, writing safe protocols, adjusting premeds, and making busulfan PK possible.
Thank you, clinical pharmacists. As #PharmacyWeek wraps up, we see you. 💊
@UPMCHillmanCC @UPMC
Missed some of the recent major oncology meetings? No worries, we've got you covered.
I'm pleased to be co-chairing Cancer Updates From Major Oncology Meetings – Pittsburgh with Dr. Adam Brufsky, and presenting Updates in Hematologic Malignancies.
📍 Sheraton Pittsburgh Hotel at Station Square
Topics covered:
🫁 Lung cancers
🔬 GI cancers
💗 Breast cancers
💙 GU cancers
🩸 Hematologic malignancies (my session)
Looking forward to sharing the latest developments and reconnecting with colleagues in Pittsburgh!
🎓 1.75 CME credits
🆓 Free registration for all healthcare providers
totalhealthoncology.com/upco…
Germline DDX41 in MDS & allo-HCT (CIBMTR, n=1,514) — Gagelmann, Lindsley et al, @BloodJournal
• 3.2% carry P/LP DDX41
• 2-yr relapse 17% vs 34% (sHR 0.43)
• DFS HR 0.62
• No excess NRM or GVHD
Test for DDX41 before transplant. RIC looks like a sound choice.ashpublications.org/blood/ar… #BMTsm @NicoGagelmann
Salman Fazal M.D retweeted
On #WorldMentalHealthDay some reminders that:
1) comparison is the thief of joy
2) your outcomes don’t entirely determine your value
3) self-care isn’t selfish
Salman Fazal M.D retweeted
Oral AZA provides benefit following CPX-351 #leusm
>>> Oral Azacitidine Maintenance After CPX-351 in Transplant-Ineligible Patients With Therapy-Related or Myelodysplasia-Related Acute Myeloid Leukemia onlinelibrary.wiley.com/doi/…
Salman Fazal M.D retweeted
For our community colleagues looking for guidance on operationalizing bispecific antibodies in their practice (inpatient or outpatient), this paper is a must read! 🔥👇🏽
#mmsm
@JCOOP_ASCO @MSKCancerCenter @MSK_DeptOfMed @kordeneha1 @CarlynRTanMD @HiraSMian
pubmed.ncbi.nlm.nih.gov/4230…
Salman Fazal M.D retweeted
Relapsed Hodgkin lymphoma: should all patients receive an autologous stem cell transplant? haematologica.org/article/vi… #lymsm
Salman Fazal M.D retweeted
👉👉👉Thank you 🙏 @VJHemOnc & and to our MPN & MDS communities for the invitation- I was honored to deliver a Keynote talk this year at the iwMDS /iwMPN meeting on #BPDCN Exciting Progress & Major Updates for 2026 & Beyond | @AmiBPatelMD @TheElfLab @mpdrc @harrisoncn1
Great framing from Tanya Wroblewski (FDA) at #iwMDS & #iwMPN: strength of evidence is what separates surrogate endpoints.
✅ Validated: known to predict clinical benefit (BP ↓ → stroke ↓)
🔶 Reasonably likely surrogate: expected to predict benefit, the basis for accelerated approval
#MPNsm #MDSsm @VJHemOnc #iwMDSMPN26
Salman Fazal M.D retweeted
📰Topline data from the phase 3 portion of the AZTOUND trial showed oral azacitidine and cedazuridine met the pharmacokinetic primary end point in patients with MDS or CMML #mpnsm #leusm #oncology
Read more: onclive.com/view/oral-azacit…
Salman Fazal M.D retweeted
Recognizing the Essential Role of APPs in Cancer Care - Salman Fazal (@salmanf)
oncodaily.com/voices/salman-…
Salman Fazal M.D retweeted
Pick any medical specialty other than your own. Who’s the most famous physician in it? You probably can’t name one.
Almost none of us will be known outside our field, and even those who achieve real professional fame are mostly forgotten within a few decades.
Fame is a poor reason to devote your life to medicine. The work itself matters more: caring for patients, discovering new knowledge, and teaching the next generation.
Salman Fazal M.D retweeted
A rare case of chronic myeloid leukemia (CML) myeloid blast phase revealed a novel NUP98::HOXC12 fusion, expanding the spectrum of NUP98 rearrangements and providing new insights into the clonal evolution of CML.
haematologica.org/article/vi…
During National APP Week, I’m grateful for the NPs and PAs who make cancer care possible every day. In hematology, transplant, and cellular therapy, I’ve seen you bring clarity to frightening moments and stand beside patients and families through their hardest days. Thank you for your heart. ❤️
@UPMCPhysicianEd @UPMCHillmanCC @BloodCancerUtd @UPMC #medtwitter
Salman Fazal M.D retweeted
What Patients Remember Most About Their Cancer Journey? - Salman Fazal (@salmanf)
oncodaily.com/?p=593367&prev…
Practice-Changing Advances From ASCO 2026: New Strategies for Myelofibrosis, AML, and Ph+ ALL vumedi.com/video/practice-ch… via @vumedi
Telomerase Inhibition in MPNs: Exploring Imetelstat as a Disease-Modifying Strategy vumedi.com/video/telomerase-… via @vumedi
